







Improved Mos1-mediated transgenesis in C. elegans 
 
To the Editor:  
The ability to add or delete genes to the genome of genetic model organisms is essential. Previously, we 
developed methods based on the Mos1 transposon1 to make targeted transgene insertions (Mos1-mediated Single 
Copy transgene Insertions, MosSCI2) and targeted deletions (Mos1-mediated deletions, MosDEL3) in 
Caenorhabditis elegans, the latter reported in your pages.  Here, we present new reagents that improve the 
efficiency, facilitate the selection for transgenic strains and expand the set of MosSCI insertion sites.  
 The Mos1 transposase is expressed from a helper plasmid co-injected with template DNA. Increased 
transposase expression would be expected to improve both single copy insertions and targeted gene deletions. We 
tested several promoters driving transposase expression for their effect on MosSCI and MosDEL efficiency (Fig. 1a 
and Supplementary Fig. 1). Relative to the glh-2 promoter, the most effective promoter (eft-3) resulted in a more 
than 6-fold improvement in transgene insertion efficiency (from 8% to 54% of worms) and gene deletion efficiency 
(from 3%, n = 66 worms2 to 20%, n = 30 worms, Fig. 1b). 
An effective, inducible negative selection marker would facilitate identification of transgenic strains. We 
developed a negative selection marker (Phsp-16.41::peel-1) based on the toxin peel-1 4. Array worms carrying the 
peel-1 plasmid are killed by a two-hour heat-shock at 34ºC with approximately 10% false positives (2/19 transgenic 
worms) (Fig. 1c and Supplementary Fig. 2). A positive selection marker is critical for identifying transgenic worms 
with insertions or deletions and we have used unc-119(+) extensively. Recently, antibiotic selection markers have 
been developed for nematode transgenesis5,6. Targeted dpy-13 deletions were generated with Neomycin/G418 
selection at frequencies comparable to unc-119 selection (24%, 12/51 worms, Fig. 1b), see Supplementary Methods 
for a discussion of the recommended use of selection markers.  
 Multiple insertion sites are important for generating complex genotypes. We have expanded the number of 
MosSCI insertion sites from two to six (Supplementary Fig. 3) with a full set of outcrossed strains containing the 
Mos1 insertion and targeting vectors (three-way Gateway or multiple cloning site compatible) based on unc-119 
selection and for one site, unc-18 selection (Table 1). All sites readily generate MosSCI inserts and express in 
somatic tissue. Three of the insertion sites (ttTi4348 I, ttTi5605 II and cxTi10816 IV) express robustly in the 
germline from a ubiquitous promoter (Supplementary Fig. 4).  Because MosSCI reagents are important for 
expression in the germline, we generated an expression vector that coexpresses GFP-histone for confirmation of 
expression (Supplementary Fig. 5). All strains are available from the Caenorhabditis elegans Genetics Center 
(CGC) and plasmids (targeting, transposase and negative selection vectors) from Addgene. 
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  Improvements to Mos1-based genome manipulation. (a) A plasmid expressing transposase under the indicated 
promoters was coinjected with low DNA concentration (32.5 ng/ul) of a 4.4 kb transgene. The plot shows insertion 
frequency into the ttTi5605 locus. (b) The plot shows the frequency of a 5 kb targeted deletion of dpy-13. Pglh-2 
data from Frøkjær-Jensen et al (2010)2 using the indicated selection markers (see Supplementary Methods for 
discussion). (c) Insertion frequency with higher total DNA concentrations (~100 ng/ul) and in the presence of the 
negative selection marker peel-1. Bar shading indicates the promoter driving Mos1 transposase: green = glh-2, blue 


















ttTi4348 I:-5.32 EG6701 pCFJ210 pCFJ352 yes 25% (3/12) EG6173 
ttTi4391 I:7.93 EG6702 pCFJ604 pCFJ353 no 29% (4/14) EG6171 
ttTi5605 II:0.77 EG6699 pCFJ150 pCFJ350 yes 43% (6/14) EG6070 
cxTi10816 IV:1.41 EG6703 pCFJ212 pCFJ356 yes 20% (2/10) EG6401 
cxTi10882 IV:-0.05 EG6700 pCFJ201 pCFJ351 variable 29% (4/14) EG5568 
ttTi14024 X:22.84 EG6705 pCFJ606 pCFJ355 limited 21% (3/14) EG6109 
unc-18 selection5 
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14x outcrossed, distributed with extrachromosomal unc-119 rescue to facilitate handling and maintenance. 
2pDESTR4-R3, three-way Gateway Compatible vector. 3Based on germline expression of Pdpy-30::GFP::H2B 
transgene. 4Insertion frequency of Pdpy-30::GFP::H2B transgene. 
unc-119 is necessary for nervous system development and unc-18 is necessary for neurotransmission. Both mutants 






Supplementary File  Title 
Supplementary Figure 1   Mos1 transposase optimization 
Supplementary Figure 2 peel-1 negative selection 
Supplementary Figure 3 Germline expression from Pdpy-30::GFP::H2B transgene 
Supplementary Figure 4 Germline expression from operon sensor construct 
Supplementary Figure 5 Overview of MosSCI insertion sites 
Supplementary Table 1   Insertion sites, Vectors and Addgene Accession numbers 
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n = 26 n = 56
70 %




n = 43 n = 38 n = 37
80 %
n = 38














































































b  Hyperactive transposase variants





Optimizing Mos1 transposase. (a) Several dierent promoters were tested to enhance MosSCI insertion frequencies. 
All injections were done at low DNA concentration (32.5 ng/ul) to disfavor extrachromosomal array formation and 
to be in the dynamic range to detect dierences in insertion frequencies. The eft-3 promoter is the most ecient 
promoter tested both as a PCR stitched construct ("standard cloning constructs") or as a three-fragment Gateway 
construct. Signicance was determined using Fischer’s exact test compared pairwise to Pglh-2. (b) Several hyper-
active Mos1 transposase mutations have been published (Germon et al., 2009) that increase transposition in vitro. 
We tested two of the most promising mutations but could not detect enhanced transposition in vivo. 






























a   Effect of peel-1 on insertion frequency. 





















6 hours after heat shock
peel-1 induced toxicity. 
Eect of peel-1 on insertion frequency. peel-1 can be used as a negative selection marker against extra-
chromosomal arrays. (a) Bar graph of MosSCI insertions with and without the negative selection marker peel-1. 
peel-1 is driven by a heat-shock promoter (Phsp16.41:peel-1) and kills animals with arrays after a two-hour 
heat-shock at 34ºC. For both Pglh-2 and Ppie-1 driven Mos1 transposase the inclusion of peel-1 greatly enhances
 the speed and ability to isolate MosSCI inserts at the expense of a moderate decrease in the insertion frequency. 
Fischer’s exact test. n = number of successfully injected animals. (b) Images of a plate of transgenic progeny from 
unc-119(-) P0s injected with 10 ng/ul Phsp::peel-1 added to an injection mix containing a unc-119(+) transgene 
and red co-injection markers (total concentration 100 ng/ul). Image to the left shows rescued animals before heat-
shock, image to the right shows animals after a two hour heat-shock at 34ºC and four hour incubation at room 
temperature. Animals rescued by the peel-1 containing array are killed and essentially disintegrate. Putative 
MosSCI insertions were selected based on viability after heat-shock without the use of a uorescence microscope 
to detect the red co-injection markers.  We observed a 10% false positive rate (2 of 19 selected animals contained 































Supplementary Figure 3, Frøkjær-Jensen et al.
Validated MosSCI sites. Mos insertions (black arrows) were obtained from NemaGENETAG and outcrossed 4X to PS6038 (11x outcrossed unc-119(ed3)). 
Sites were identied on all chromosomes except chromosome III, which contains the selection marker unc-119(-), and chromosome V for which no 
adequate sites were identied. Each of these sites are in intergenic regions, most between annotated genes in a tail-to-tail conguration.  Targeting 
vectors (three-way Gateway and multiple cloning site compatible) with the unc-119(+) selectable marker have been constructed for each insertion site. 
For one site (ttTi4348 I), we also generated an insertion strain with unc-18(-) and a targeting vectors with an unc-18(+) gene for selection to facilitate 
making double insertion MosSCI strains. 
oxSi468 (cxTi10882 IV)
oxSi466 (ttTi5605 II)
Supplementary Figure 4 , Frøkjær-Jensen et al.















Somatic and germline expression of Pdpy-30::GFP::H2B inserts into MosSCI sites . 
Black arrowhead = proximal gonad, oocytes. White arrowhead = distal gonad. (a) Consistent expression. Three 
MosSCI sites (ttTi4348 I, ttTi5605 II and cxTi10816 IV) exhibited consistent and bright somatic and germline 
expression of a Pdpy-30::GFP::H2B construct. (b) Restricted expression. Two MosSCI sites showed restricted or no 
germline expression, either to only the proximal arm of the gonad (ttTi14024 X) or no visible expression
anywhere in the germline (ttTi4391 I). For both sites, expression in somatic tissues appeared normal. oxSi474: left 
image, no germline expression in adult. right image, ubiquitous somatic expression in L1 animal. (c) One MosSCI site 
(cxTi10882 IV) displayed variable expression in the germline. oxSi468: left image, dim expression in proximal gonad, 
no expression in distal gonad. right image, ubiquitous somatic expression in L1 animal.  
Abbreviated gure legend. For full gure legend see Supplementary Materials.



























Germline uorescence. (a) Schematic of the expression construct pCFJ359 which was inserted into the ttTi5605 
site to test germline expression (unc-119 and homology arms omitted for clarity). The third gateway slot (attB3-
attB2) serves as a sensor for germline expression of the second attB1-attB2 gateway slot by expressing GFP-H2B. 
In the schematic, the second slot (attB1-attB2) contains mCherry::H2B but any gene of interest could be cloned 
into a [1-2] Gateway entry vector. The entry vector pCFJ359 contains the tbb-2utr:operon:GFP::H2B:cye-1utr 
transgene. (b) An example of expression of the construct in the hermaphrodite (left) and male (right) germlines. 
29% of all lines (11 of 38 independent inserts) showed germline uorescence. In all cases where we observed GFP
uorescence we also observed mCherry uorescence. 
Supplementary Table 1 - Frøkjær-Jensen et al., 2011
 Plasmids submitted to addgene
Plasmid Name Description Addgene ID #
pCFJ604 pDESTR4-R3(ttTi4391, I) ttTi4391 Gateway targeting vector #34861
pCFJ606 pDESTR4-R3(ttTi14024, X) ttTi14024 Gateway targeting vector #34862
pCFJ210 pDESTR4-R3(ttTi4348, I) ttTi4348 Gateway targeting vector #34863
pCFJ212 pDESTR4-R3(cxTi10816, IV) cxTi10816 Gateway targeting vector #34864
pCFJ448 pDESTR4-R3(ttTi4348, I, unc-18) ttTi4348 Gateway targeting vector, unc-18 selection #34865
pCFJ350 MCS(ttTi5605, II) ttTi5605 MCS targeting vector #34866
pCFJ351 MCS(cxTi10882, IV) cxTi10882 MCS targeting vector #34867
pCFJ352 MCS(ttTi4348, I) ttTi4348 MCS targeting vector #34868
pCFJ353 MCS(ttTi4391, I) ttTi4391 MCS targeting vector #34869
pCFJ355 MCS(ttTi14024, X) ttTi14024 MCS targeting vector #34870
pCFJ356 MCS(cxTi10816, IV) cxTi10816 MCS targeting vector #34871
pCFJ676 MCS(ttTi4348, I, unc-18(+)) ttTi4348 MCS targeting vector, unc-18 selection #34872
pMA122 peel-1 negative selection heat-shock inducible negative selection marker #34873
pCFJ601 Peft-3 Mos1 transposase Improved Mos1 transposition #34874
pCFJ326 operon for germline expression Monitor germline expression with operon #34875
pCFJ421 Pmyo-2::GFP::H2B (pharynx) Co-injection marker, green pharyngeal muscle expression #34876
pCFJ420 Peft-3::GFP::H2B (ubiquitous) Co-injection marker, ubiquitous green expression. #34877
pCFJ594 pENTR[1-2](NeoR) Neomycin resistance, [1-2] gateway slot for MosDEL constructs #34878
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We maintain a website with up to date information on protocols, reagents and characteristics of the different 
MosSCI insertion sites.  















Mos1 insertion alleles were selected by visual screening in Wormbase (www.wormbase.org) for transposon 
insertions in intergenic regions. All insertion strains were provided by the NemaGENETAG consortium. Mos1 
insertions were homozygosed and followed in crosses by PCR. Strains were maintained on NGM plates seeded with 
OP50 or HB101 bacteria. 
 
Strains used in the study (Table 1): 
Injection strains 
EG6699: ttTi5605 II; unc-119(ed3) III; oxEx1578[cb-unc-119(+); Peft-3::GFP]   
EG6700: unc-119(ed3) III; cxTi10882 IV; oxEx1579[cb-unc-119(+); Peft-3::GFP]  
EG6701: ttTi4348 I; unc-119(ed3) III; oxEx1580[cb-unc-119(+); Peft-3::GFP]  
EG6702: ttTi4391 I; unc-119(ed3) III; oxEx1581[cb-unc-119(+); Peft-3::GFP]   
EG6703: unc-119(ed3) III; cxTi10816 IV; oxEx1582[cb-unc-119(+); Peft-3::GFP]  
EG6705: unc-119(ed3) III; ttTi14024 X; oxEx1584[cb-unc-119(+); Peft-3::GFP]  
Strains were outcrossed and rescued with extra-chromosomal arrays to facilitate freezing, maintenance and 
distribution. Injections were performed using derivatives of these strains that have lost the rescuing arrays.  
 
Outcrossing strains 
EG6843: unc-119(ed3) III; him-5(e1490) V; oxEx1605[cb-unc-119(+); Phsp-16.41::peel-1]. 
This strain is useful for outcrossing MosSCI insertions. The Him Unc-119(+) males can be crossed into the MosSCI 
strains with inserts. In the second or third generation from a cross, the array can be selected against by heat-shock, 
so the only rescue comes from the MosSCI insert.  
 
PS6038: unc-119(ed3) III ; syEx1136[Pmyo-2::GFP; unc-119(+)l].  
11x outcross of unc-119(ed3) to N2 by Amir Sapir from the Sternberg Lab. This strain is useful for outcrossing 
MosSCI inserts. Cross males (for example, from a cross with EG6843 above) containing MosSCI insertions to 
animals from this strain that have lost the array rescue.  
 
Balancer strains 
EG6173: oxSi259[Peft-3::GFP cb-unc-119(+)] I; unc-119(ed3) III 
EG6171: oxSi257[Peft-3::GFP cb-unc-119(+)] I; unc-119(ed3) III   
EG6070: oxSi221[Peft-3::GFP cb-unc-119(+)] II; unc-119(ed3) III   
EG6401: unc-119(ed3) III; oxSi346[Peft-3::GFP cb-unc-119(+)] IV   
EG5568: dpy-13(ox495::cb-unc-119(+) Pmyo-2::mCherry Punc-122::GFP) IV   
EG6109: unc-119(ed3) III; oxSi230[Peft-3::GFP cb-unc-119(+)] X  
These GFP expressing chromosomes can be bounced out to homozygose the Mos bearing chromosome or a MosSCI 
insertion when crossing in other mutations. 
 
Pdpy-30::GFP::H2B::tbb-2 strains 
Consistent germline expression: 
EG6776: oxSi471[Pdpy-30::GFP::H2B::tbb-2; cb-unc-119(+)] I; unc-119(ed3) III  
EG6771: oxSi466[Pdpy-30::GFP::H2B::tbb-2; cb-unc-119(+)] II; unc-119(ed3) III   
EG6781: unc-119(ed3) III; oxSi476[Pdpy-30::GFP::H2B::tbb-2; cb-unc-119(+)] IV   
Restricted germline expression: 
EG6782: unc-119(ed3) III; oxSi477[Pdpy-30::GFP::H2B::tbb-2; cb-unc-119(+)] X 
EG6779: oxSi474[Pdpy-30::GFP::H2B::tbb-2; cb-unc-119(+)] I; unc-119(ed3) III   
Variable germline expression: 
EG6775: unc-119(ed3) III; oxSi470[Pdpy-30::GFP::H2B::tbb-2; cb-unc-119(+)] IV   
EG6773: oxSi468[Pdpy-30::GFP::H2B::tbb-2 cb-unc-119(+)] IV; unc-119(ed3) III   
 
Pmex-5::mCherry::H2B::tbb-2utr:operon:GFP::H2B::cye-1utr strains 
EG6787: oxSi487[Pmex-5::mCherry::H2B::tbb-2:operon:GFP::H2B::cye-1utr; unc-119(+)] II; unc-119(ed3) III   
 
dpy-13 deletion strains 




EG5568 is a rare complex deletion/insertion. The dpy-13 deletion is linked to an insertion of a Pmyo-2::mCherry co-
injection marker. Presumably the template that repaired the Mos1 excision incorporated the selection marker Pmyo-
2::mCherry from the extrachromosomal array.  
EG7003: dpy-13(ox497::neoR(+)) IV 
 
Protocol	  for	  MosSCI	  insertions	  
We followed the protocol described in Frøkjær-Jensen et al. (2008) with a few modifications. First, all injection 
strains were grown on HB101 bacteria at 15ºC. The unc-119 and unc-18 strains are healthier on HB101 bacteria 
which facilitates injection and survival. The HB101 bacteria can be requested from the Caenorhabditis Genetics 
Center (CGC). Second, plates with a single injected worm were placed in a humidified 25ºC incubator within two 
hours of injection and left there until starvation. Growth at 25ºC shortens the time needed to recover insertions. 
Three days after injection the plates were screened for Unc-119(+) rescue; any plates with rescued progeny were 
kept and counted as successfully injected. After starving completely (approximately a week after injection), plates 
were screened for MosSCI inserts on a fluorescence dissecting microscope. MosSCI insertions can be distinguished 
by wild-type movement, the lack of red co-injection markers and a propensity to form dauers faster than array-
rescued unc-119 animals.  
Other specific modifications are listed below.  
Low DNA concentration 
The data shown in Fig. 1a and Supplementary Fig. 1a/b were generated by injecting a total concentration of 32.5 
ng/ul. By injecting low concentrations of DNA, F1 rescue is promoted but F2 stable array formation is inhibited 
(Mello et al., 1991). The reduced number of stable extrachromosomal arrays facilitates screening for inserts. Also, a 
lower concentration of the targeting vector facilitates insertions if the targeting vector is toxic at high concentrations.  
A 10x MosSCI injection mix was made with 50 ng/ul pCFJ104 (Pmyo-3:mCherry), 50 ng/ul pGH8 (Prab-
3:mCherry), 25 ng/ul pCFJ90 (Pmyo-2:mCherry) and 100ng/ul of the Mos1 transposase plasmid (for example, 
pCFJ601). Injection mixes were typically made up in 20 ul volumes by adding 2 ul 10x MosSCI injection mix, 10 
ng/ul (final concentration) targeting vector and distilled water up to 20 ul.  
 
High DNA concentration + peel-1 
Although toxicity is minimized and screening for inserts is facilitated by low DNA concentration the overall 
frequency of insertions is reduced (see for example Pglh-2 in Fig. 1a vs Supplementary Fig. 2a). We therefore 
developed a method to select against animals carrying arrays by heat-shock. The peel-1 gene encodes a cell 
autonomous toxin that can kill animals within hours by ectopic expression (Seidel et al., 2011). We included a Phsp-
16.41::peel-1::tbb-2utr plasmid (pMA122) in the injection mix at 10 ng/ul to express peel-1 after a 2 hour heat-
shock at 34ºC in an air incubator.  Final concentration of total injected DNA was 100 - 110 ng/ul. 
Pglh-2:: Transposase  
Injections were done at the original concentrations described in Frøkjær-Jensen et al. (2008), with the targeting 
vector injected at 50 ng/ul, pJL43.1(Pglh-2:: transposase) at 50 ng/ul, pGH8 (Prab-3:mCherry) at 10 ng/ul, pCFJ90 
(Pmyo-2:mCherry) at 2.5 ng/ul and pCFJ104 (Pmyo-3:mCherry) at 5 ng/ul. pMA122 (Phsp-16.41:peel-1) was 
omitted or included at 10 ng/ul.  
Ppie-1:: Transposase 
Injections were done with the following concentrations: Targeting vector at 10 ng/ul, Ppie-1:: Transposase at 25 
ng/ul, pGH8 (Prab-3:mCherry) at 10 ng/ul, pCFJ90 (Pmyo-2:mCherry) at 2.5 ng/ul and pCFJ104 (Pmyo-
3:mCherry) at 5 ng/ul. pMA122 (Phsp-16.41:peel-1) was omitted or included at 10 ng/ul. In initial experiments, 
Ppie-1:: Transposase appeared to be toxic at 50 ng/ul (data not shown) and the concentration was therefore reduced 
to 25 ng/ul.  
The injected animals were placed at 25ºC after injection and allowed to starve out. Starved plates were heat-shocked 
for 2 hours at 34ºC in an air incubator and screened for living Unc-119(+) animals either four hours later or a day 
later. The heat-shock kills almost all animals with extrachromosomal arrays and greatly facilitates screening. We 
observe an approximate 10% false positive rate if we pick Unc-119(+) adults on a regular transmitted light 





Comments	  on	  the	  use	  of	  the	  negative	  selection	  marker	  peel-­‐1	  	  
At first glance the use of the negative selection marker may seem disadvantageous.  Use of the negative selection 
marker requires an additional step (2 hours of heat-shock at 34ºC) and reduces the insertion frequency (see 
Supplementary Figure 2). However in our hands, these disadvantages are more than compensated for by the 
reduction in time screening for inserts and the ability to screen without using a fluorescence microscope. Although 
the low DNA concentration reduces array formation there are still often array containing animals on the plates that 
make screening somewhat laborious. Moreover, the insertion frequency with a low DNA concentration is similar to 
the insertion frequency of a high DNA concentration together with the hsp::peel-1 negative selection plasmid (54% 
vs 62%, respectively for Peft-3::transposase). In our lab, we exclusively use the protocol using a high DNA 
concentration with the Peft-3 helper plasmid and the peel-1 negative selection marker.  
 
Protocol	  MosDEL	  injections	  
We followed the protocol described in Frøkjær-Jensen et al. (2010) with the same modifications described above: 
strains were grown on HB101 bacteria at 15ºC before injection and injected worms were placed at 25ºC after 
injection. Further changes to the protocol are described below. 
unc-119 selection 
We tested the efficiency of using Peft-3::mosase and the negative selection marker peel-1 to generate a 5kb targeted 
deletion of dpy-13 with the Mos1 element at cxTi10882. We used the plasmid pRL5 described in Frøkjær-Jensen et 
al. (2010). The injection mix consisted of pRL5 (5 kb deletion construct) at 50 ng/ul, pCFJ104 (Pmyo-3:mCherry) at 
5 ng/ul, pGH8 (Prab-3:mCherry) at 10 ng/ul, pCFJ90 (Pmyo-2:mCherry) at 2.5 ng/ul, pCFJ631 (Peft-3::mos1 
transposase) at 50 ng/ul and pMA122 (Phsp-16.41::peel-1) at 10ng/ul. unc-119(ed3) III, cxTi10882 IV animals were 
injected, singled to individual plates and placed at 25ºC. Three days later the plates were screened for unc-119 
rescue; any plates with rescued progeny were kept and counted as successfully injected. Approximately a week after 
injection the plates were heat-shocked for 2 hours at 34ºC and screened for rescued animals four hours later. From 
plates with rescued progeny, a single animal was picked and allowed to self. In the next generation, the progeny 
were scored for the Dpy-13 phenotype.  
Neomycin selection 
We generated a plasmid (pCFJ662) to delete a 5kb region adjacent to cxTi10882 as described above, but with a 
neomycin selection marker in place of the unc-119(+) selection marker (see pCFJ594, Neomycin selection marker 
below). The injection mix consisted of pCFJ662 at 50 ng/ul, pCFJ104 (Pmyo-3:mCherry) at 5 ng/ul, pGH8 (Prab-
3:mCherry) at 10 ng/ul, pCFJ90 (Pmyo-2:mCherry) at 2.5 ng/ul, pCFJ631 (Peft-3::mos1 transposase) at 50 ng/ul 
and pMA122 (hsp-16.41::peel-1) at 10 ng/ul. cxTi10882 IV animals were injected, singled to individual plates and 
placed at 25ºC. Three days later the plates were screened for mCherry fluorescence; any plates with transgenic 
progeny were kept and counted as successfully injected. Plates were flooded with 500 ul of 25 mg/ml G418 
(Goldbiochem, St. Louis, MO) and allowed to dry. Approximately a week after injection the plates were heat-
shocked for 2 hours at 34ºC and chunked to a new plate and flooded with 500ul of 25 mg/ml G418. Two days later, 
the plates were screened for Dpy-13 progeny. Dpy-13 progeny were singled and propagated for a generation to 
verify homozygosity of deletion. Two (see EG7003, for example) of the dpy-13 strains were tested for G418 
resistance. Growth was similar on selection and non-selection plates, whereas N2 controls did not grow on selection 
plates.  
 
Comments	  on	  the	  use	  of	  positive	  selection	  markers	  unc-­‐119(+)	  and	  neomycin.	  
unc-119 is a very strong selection marker that has been used extensively for biolistic transformation (Praitis et al., 
2001), MosSCI (Froekjaer-Jensen et al., 2008) and MosDEL (Froekjaer-Jensen et al., 2010). unc-119 is a 
particularly strong selection marker because unc-119 animals are strongly Unc and cannot form dauer animals so 
non-rescued animals rapidly die at 25ºC (Maduro and Pilgrim, 1995). This selection makes it easy to identify inserts. 
Homozygous animals are easily identified based on the lack of Unc animals and unc-119 is a strong balancer for 
lethal deletions (Froekjaer-Jensen et al., 2010). However, unc-119 has a number of disadvantages: the mutant 
animals are sick and somewhat difficult to inject. Also, to generate Mos1 based deletions it is necessary to cross the 




For these reasons, it would be highly desirable to have a selectable marker based on a drug. Two such 
selectable antibiotic markers have been developed for C. elegans based on the antibiotics G418/Neomycin 
(Giordano-Santini et al., 2010) and Puromycin (Semple et al., 2010). The neomycin selection had been shown to be 
efficient enough to generate MosSCI inserts but not strong enough to generate biolistic inserts (Giordano-Santini et 
al., 2010). This suggested that the neomycin selection is less efficient than unc-119. Because the MosDEL efficiency 
is lower than MosSCI and because deletions often result in sick mutant animals it was not clear if neomycin would 
be strong enough to select for Mos1 mediated deletions and we therefore tested the efficiency. We did not test the 
puromycin selection because it was not used to generate biolistic inserts or to select for MosSCI insertions (Semple 
et al., 2010). However, a single copy of the puromycin resistance gene inserted with unc-119 selection is fully 
resistant to puromycin and this selection may therefore be strong enough as a selection marker on its own (Semple et 
al., 2010).  
The efficiency of dpy-13 deletions with neomycin is equal to the efficiency of unc-119 (Figure 1 C). 
However, under the conditions that we used (which are a modification of the protocol used by Giordano-Santini et 
al.) we also observed that most of the plates without a dpy-13 deletion had viable non-array worms on the G418 
selection media. We picked "non-dead" animals from these plates but they never segregated Dpy animals suggesting 
that they were false positive strains that did not contain the desired deletion. In the case of dpy-13, the deletion 
generates an obvious, non-lethal phenotype which can readily be identified and selected. However for a deletion 
where the phenotype is not known in advance - or where the deletion is lethal - we do not expect the neomycin 
selection to perform as well as unc-119 because the false positives will be difficult to distinguish from real deletions.   
We therefore recommend using neomycin for deletions with a clear, non-lethal phenotype. We recommend 
using unc-119 for deletions that are expected to be very severe or where the phenotype is not known from 




Targeting	  vectors,	  three-­‐way	  Gateway	  compatible	  
A set of targeting vectors (pDESTR4-R3) that are compatible with the three-way Gateway system (Invitrogen, 
Carlsbad, CA) were generated by standard cloning (pCFJ150, pCFJ201, pCFJ210, pCFJ212 and pCFJ448) or by 
Isothermal Assembly (Gibson et al., 2009) (pCFJ604 and pCFJ606).  
The following vectors contain the cb-unc-119 rescue marker and an attR4-ccdB-Cm-attR3 cassette flanked by 
homology regions to target MosSCI inserts. 
 
Vector Insertion site Selection Marker 
pCFJ150 ttTi5605 II unc-119(+) 
pCFJ201 cxTi10882 IV unc-119(+) 
pCFJ210 ttTi4348 I unc-119(+) 
pCFJ212 cxTi10816 IV unc-119(+) 
pCFJ604 ttTi4391 I unc-119(+) 
pCFJ606 ttTi14024 X unc-119(+) 
pCFJ448 ttTi4348 I unc-18 (+) 
 
 
Targeting	  vectors,	  Multiple	  Cloning	  Site	  (MCS)	  
A set of targeting vectors that are compatible with restriction enzyme cloning were generated by a three-way 
Gateway reaction that combines an [attB1-attB2] vector containing a cb-unc-119 rescuing fragment and a multiple 
cloning site (MCS) with M13f and M13r sequencing sites together with two flanking constructs that contain the 
homology regions to target MosSCI inserts. The three entry fragments were combined with a custom-made 





Vector Insertion site Selection Marker 
pCFJ350 ttTi5605 II unc-119(+) 
pCFJ351 cxTi10882 IV unc-119(+) 
pCFJ352 ttTi4348 I unc-119(+) 
pCFJ356 cxTi10816 IV unc-119(+) 
pCFJ353 ttTi4391 I unc-119(+) 
pCFJ606 ttTi14024 X unc-119(+) 




Mos1	  transposase	  vectors	  
A set of plasmids that drive Mos1 transposase expression under different promoters  (Supplementary Table 1) were 
generated either by PCR stitching or by three-fragment Gateway. In some cases, the introduction of Att sites 
between the promoter and the Mos1 transposase inhibited the insertion frequency (Ppie-1) and in other cases the Att 
sites appeared to enhance the insertion frequency (Peft-3).  In all cases the ATG start site was adjacent to the native 
transposase ORF and after the Att site. 
 
Non-Gateway based 
pJL43.1 (Pglh-2::mos1 transposase::glh-2utr) was described in (Bessereau et al., 2001). pCFJ103 (Ppie-
1(intron)::mos1 transposase::pie-1utr ) was generated by removing a cb-unc-119 fragment from a vector containing 
a Ppie-1::mos1 transposase fragment (pWD106) (Gallo et al., 2008). pCFJ631 (Peft-3::mos1 transposase::tbb-2utr) 
was generated by PCR stitching and verified by sequencing.  
 
Gateway based 
pCFJ601 (Peft-3::mos1 transposase::tbb-2utr), pCFJ204 (Pglh-2::mos1 transposase::tbb-2utr) and pCFJ501 (Ppie-
1::mos1 transposase::pie-1utr) were generated by a three-fragment Gateway reaction.  
 
Mutated	  transposase	  vectors	  
A set of mutated transposase plasmids were generated. The mutations were chosen based on the ability of 
hyperactivating mutations to improve transposition in bacterial assays (Germon et al., 2009). The hyperactivating 
mutations were introduced by PCR and all plasmids were verified by sequencing. All mutated versions of the Mos1 
transposase were cloned into entry vectors and inserted into expression constructs by a three-fragment Gateway 
reaction. All wild-type and modified Mos1 transposases were put under the control of a pie-1 promoter and followed 
by a pie-1 3’utr.  
The following expression constructs were used: pCFJ501 (Ppie-1::mos1 transposase(wild-type)::pie-1utr), 





A set of GFP based co-injection markers (Supplementary Table 1) were generated to facilitate insertion of 
transgenes expressing red fluorophores to complement the mCherry vectors described in Frøkjær-Jensen et al. 
(2008). All vectors were generated by three-fragment Gateway reactions.  
 
pCFJ421(Pmyo-2::GFP::H2B::tbb-2utr) expresses nuclear localized GFP in the pharyngeal muscles, pCFJ420(Peft-
3::GFP::H2B::tbb-2utr) expresses nuclear-localized GFP in all somatic tissues. pCFJ90(Pmyo-2::mCherry::unc-
54utr), pCFJ104(Pmyo-3::mCherry::unc-54utr) and pGH8(Prab-3::mCherry::unc-54utr) were described in 





Negative selection marker 
A negative selection marker based on the peel-1 toxic gene (Seidel et al., 2011) was developed to select against 
arrays following heat-shock. pMA122 (Phsp-16.41::peel-1::tbb-2utr) was generated by three fragment Gateway and 
expresses peel-1 after heat-shock induction and kills almost all array carrying animals.  
 
Miscellaneous	  vectors	  
Germline sensor construct 
pCFJ326. An important application of MosSCI is to generate transgenic animals that express a gene of interest in 
the germline (see Supplementary Fig. 4). However, not all inserts successfully express in the germline - either 
because of inefficient repair or possibly because of silencing mechanisms that are not fully understood. Also, in 
many cases it is desirable to insert an untagged gene but still monitor its expression in the germline. We therefore 
developed a vector based on an operon construct described by Merritt et al. (2008). We modified a construct to 
make a [attB2-attB3] Gateway compatible vector (pCFJ326) that contains a tbb-2utr::gpd-2:operon:GFP::H2B:cye-
1utr. We modified the construct to contain the tbb-2 utr because it allows ubiquitous expression in the germline 
(Merritt et al., 2008). We used a plasmid (pCFJ359) containing a 4.4 kb fragment insert consisting of Pmex-
5:mCherry::H2B::tbb-2utr::GFP::H2B::cye-1utr to test the efficiency. 11 of 38 inserts (29%) expressed 
fluorescence in the germline. For all 11 fluorescent inserts we saw perfect correlation between GFP and mCherry 
expression, indicating that GFP::H2B expression is a good reporter for expression of the upstream gene in the 
operon.  
 
Neomycin selection vector 
pCFJ594. We cloned a Prps-27::neomycin fragment based on pRG5273-Neomycin (Giordano-Santini et al., 2010) 
into a [attB1-attB2] Gateway entry vector. This vector can be used to generate a targeting vector for MosDEL and 
select for deletions with G418/Geneticin. 
 
Statistical	  Methods	  
All data were analyzed with the program GraphPad Prism 5 (GraphPad Software, La Jolla, CA). The proportions 
were analyzed in a contingency table and statistical significance was computed with Fischer's Exact Test. In cases 
where multiple comparisons were made with the same set of data, the significance level was adjusted for multiple 
comparisons by multiplying the P-value by the number of comparisons. 95% confidence intervals were calculated 
by the Modified Wald Method.  
 
Figure 1 










Pglh-2 45 38 3 0.08 0.020 - 0.22 
Ppie-1 29 26 6 0.23 0.11 - 0.42 




Fischer's exact test:  
Pglh-2 vs Ppie-1: P = 0.14, not significant 
Pglh-2 vs Peft-3: P < 0.01, highly significant. 
 
















Pglh-2 unc-119(+) N.D. 83 3 0.036  0.008 - 0.11 
Peft-3 unc-119(+) 47 30 6 0.20 0.09 - 0.38 




Fischer's exact test:  
Pglh-2(unc-119) vs Ppie-1(unc-119): P = p < 0.05 
Peft-3(unc-119) vs Peft-3(neomycin): P = 0.78, not significant.  
 
 










Pglh-2 46 43 12 0.28 0.17 - 0.43 
Ppie-1 48 38 15 0.39 0.26 - 0.55 




Fischer's exact test:  
Pglh-2 vs Ppie-1: P = 0.35, not significant 
Pglh-2 vs Peft-3: P = p < 0.05  
 
Supplementary Figure 1 
 










Pglh-2 (MCS) 45 38 3 0.08 0.020 - 0.22 
Ppie-1 (MCS) 29 26 6 0.23 0.11 - 0.42 
Peft-3 (MCS) 59 41 12 0.32 0.19 - 0.47 
Ppie-1 (Gateway) 31 26 3 0.12 0.03 - 0.30 




Fischer's exact test: 
Pglh-2 vs Peft-3 (standard cloning): p < 0.05 
Pglh-2 vs Peft-3(gateway): p < 0.01 
 













wildtype 31 26 3 0.12 0.03 - 0.30 
T216A 37 26 1 0.04 0.00-0.20 
E137K, 
T216A 
32 26 1 0.04 0.00-0.20 
 
 
The transposase variants did not improve insertion frequency.  
  











Pglh-2 35 34 16 0.47 0.31 - 0.63 
Pglh-2 + peel-1 46 43 12 0.28 0.17 - 0.43 
Ppie-1 45 38 26 0.68 0.68 - 0.52 




Fischer's exact test: 
Pglh-2 vs Pglh-2 + peel-1: not significant 
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